TF and pulmonary arterial hypertension: We will also propose perspectives that link metabolic alterations to potential TF-PTMs influencing the behavior of blood vasculature in four paradigmatic pathological scenarios: atherosclerosis, diabetes, tumor angiogenesis and pulmonary arterial hypertension (PAH).